Myriad Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Myriad Genetics's estimated annual revenue is currently $727M per year.
- Myriad Genetics's estimated revenue per employee is $192,328
- Myriad Genetics's current valuation is $2.2B. (January 2022)
Employee Data
- Myriad Genetics has 3780 Employees.
Myriad Genetics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Customer Operations Group | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | SVP, Government Affairs & Public Policy | Reveal Email/Phone |
4 | SVP, Transformation and Chief Staff to the CEO | Reveal Email/Phone |
5 | VP Software Engineering - R&D Platform | Reveal Email/Phone |
6 | VP Customer Experience & Digital Strategy | Reveal Email/Phone |
7 | VP Software Engineering | Reveal Email/Phone |
8 | VP, HR | Reveal Email/Phone |
9 | SVP, Chief Accounting Officer | Reveal Email/Phone |
10 | VP Customer Service | Reveal Email/Phone |
Myriad Genetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $434.8M | 1865 | -14% | $2B | $2.7B |
#2 | $59.2M | 163 | 1% | $32.3M | N/A |
What Is Myriad Genetics?
N/A
Total Funding
3780
Number of Employees
$727M
Revenue (est)
N/A
Employee Growth %
$2.2B
Valuation
N/A
Accelerator
Myriad Genetics News
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad...
In trading on Monday, shares of Myriad Genetics, Inc. (Symbol: MYGN) entered into oversold territory, hitting an RSI reading of 29.0,...
SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Eric Santa as its new Chief Growth Officer. In this role, he will be responsible for accelerating growth initiatives and building commercia ...
SALT LAKE CITY, March 02, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with Intermountain Precision Genomics, a service of Intermountain Healthcare. This collabo ...
SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new technology and healthcare leaders who recently joined the company as well as key promotions to drive critical business functions ...
Other Companies in Salt Lake City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3250M | 3809 | 2% | $87.9M |
#2 | N/A | 4795 | 7% | N/A |
#3 | $1209.3M | 4799 | N/A | N/A |
#4 | $1283.9M | 5095 | -1% | N/A |
#5 | $2343.6M | 9105 | 10% | N/A |